Please wait a moment until all data is loaded. This message will disappear when all data is loaded.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
2,6-diaminopimelate + O2 + H2O
?
-
Substrates: 22% activity compared to L-lysine
Products: -
?
5-hydroxy-DL-lysine + O2 + H2O
6-amino-5-hydroxy-2-oxohexanoate + NH3 + H2O2
-
Substrates: 5% activity compared to L-lysine
Products: -
?
L-arginine + O2 + H2O
5-carbamidamido-2-oxopentanoate + NH3 + H2O2
L-arginine + O2 + H2O
5-guanidino-2-oxopentanoate + NH3 + H2O2
L-histidine + O2 + H2O
3-(1H-imidazol-4-yl)-2-oxopropanoate + NH3 + H2O2
L-leucine + O2 + H2O
4-methyl-2-oxopentanoate + NH3 + H2O2
L-lysine + O2 + H2O
6-amino-2-oxohexanoate + NH3 + H2O2
L-lysine + semicarbazide + ?
4-methyl-2-oxopentanoate + ?
-
Substrates: -
Products: -
?
L-ornithine + O2 + H2O
5-amino-2-oxopentanoate + NH3 + H2O2
L-ornithine + O2 + H2O
5-amino-2-oxopentanoic acid + NH3 + H2O2
L-phenylalanine + O2 + H2O
phenylpyruvate + NH3 + H2O2
L-tyrosine + O2 + H2O
3-(4-hydroxyphenyl)pyruvate + NH3 + H2O2
-
Substrates: -
Products: -
?
L-tyrosine + O2 + H2O
4-hydroxyphenylpyruvate + NH3 + H2O2
-
Substrates: 1.4% activity compared to L-lysine
Products: -
?
additional information
?
-
L-arginine + O2 + H2O
5-carbamidamido-2-oxopentanoate + NH3 + H2O2
-
Substrates: 5.8% activity compared to L-lysine
Products: -
?
L-arginine + O2 + H2O
5-carbamidamido-2-oxopentanoate + NH3 + H2O2
Trichoderma cf. aureoviride
-
Substrates: 8.3% activity compared to L-lysine
Products: -
?
L-arginine + O2 + H2O
5-carbamidamido-2-oxopentanoate + NH3 + H2O2
Trichoderma cf. aureoviride Rifai VKM F-4268D
-
Substrates: 8.3% activity compared to L-lysine
Products: -
?
L-arginine + O2 + H2O
5-guanidino-2-oxopentanoate + NH3 + H2O2
-
Substrates: 12.8% activity compared to L-lysine
Products: -
?
L-arginine + O2 + H2O
5-guanidino-2-oxopentanoate + NH3 + H2O2
-
Substrates: -
Products: -
?
L-arginine + O2 + H2O
5-guanidino-2-oxopentanoate + NH3 + H2O2
-
Substrates: -
Products: -
?
L-arginine + O2 + H2O
5-guanidino-2-oxopentanoate + NH3 + H2O2
-
Substrates: 6.3% activity compared to L-lysine
Products: -
?
L-arginine + O2 + H2O
5-guanidino-2-oxopentanoate + NH3 + H2O2
-
Substrates: -
Products: -
?
L-arginine + O2 + H2O
5-guanidino-2-oxopentanoate + NH3 + H2O2
-
Substrates: 6.3% activity compared to L-lysine
Products: -
?
L-histidine + O2 + H2O
3-(1H-imidazol-4-yl)-2-oxopropanoate + NH3 + H2O2
-
Substrates: -
Products: -
?
L-histidine + O2 + H2O
3-(1H-imidazol-4-yl)-2-oxopropanoate + NH3 + H2O2
-
Substrates: only 1% in comparison with L-lysine
Products: -
?
L-leucine + O2 + H2O
4-methyl-2-oxopentanoate + NH3 + H2O2
-
Substrates: -
Products: -
?
L-leucine + O2 + H2O
4-methyl-2-oxopentanoate + NH3 + H2O2
-
Substrates: -
Products: -
?
L-lysine + O2 + H2O
6-amino-2-oxohexanoate + NH3 + H2O2
-
Substrates: -
Products: -
?
L-lysine + O2 + H2O
6-amino-2-oxohexanoate + NH3 + H2O2
Substrates: enzymes with dual activities in a single active site: L-lysine oxidase and L-lysine monooxygenase
Products: -
?
L-lysine + O2 + H2O
6-amino-2-oxohexanoate + NH3 + H2O2
Substrates: the mechanistic features are reported that are important for allowing the single active site of L-LOX/MOG to catalyze the two reactions of apparent monooxygenation and the oxidation of the flavoprotein oxidase
Products: -
?
L-lysine + O2 + H2O
6-amino-2-oxohexanoate + NH3 + H2O2
-
Substrates: -
Products: -
?
L-lysine + O2 + H2O
6-amino-2-oxohexanoate + NH3 + H2O2
-
Substrates: -
Products: -
?
L-lysine + O2 + H2O
6-amino-2-oxohexanoate + NH3 + H2O2
-
Substrates: -
Products: -
?
L-lysine + O2 + H2O
6-amino-2-oxohexanoate + NH3 + H2O2
-
Substrates: 100% activity
Products: -
?
L-lysine + O2 + H2O
6-amino-2-oxohexanoate + NH3 + H2O2
-
Substrates: -
Products: -
?
L-lysine + O2 + H2O
6-amino-2-oxohexanoate + NH3 + H2O2
-
Substrates: -
Products: -
?
L-lysine + O2 + H2O
6-amino-2-oxohexanoate + NH3 + H2O2
-
Substrates: 100% activity
Products: -
?
L-lysine + O2 + H2O
6-amino-2-oxohexanoate + NH3 + H2O2
Trichoderma aureoviride Rifai VKM F-4268D
-
Substrates: -
Products: -
?
L-lysine + O2 + H2O
6-amino-2-oxohexanoate + NH3 + H2O2
Trichoderma cf. aureoviride
-
Substrates: -
Products: -
?
L-lysine + O2 + H2O
6-amino-2-oxohexanoate + NH3 + H2O2
Trichoderma cf. aureoviride
-
Substrates: the stereospecific enzyme oxidizes almost exclusively L-lysine
Products: -
?
L-lysine + O2 + H2O
6-amino-2-oxohexanoate + NH3 + H2O2
Trichoderma cf. aureoviride Rifai VKM F-4268D
-
Substrates: the stereospecific enzyme oxidizes almost exclusively L-lysine
Products: -
?
L-lysine + O2 + H2O
6-amino-2-oxohexanoate + NH3 + H2O2
Trichoderma cf. aureoviride Rifai VKM F-4268D
-
Substrates: -
Products: -
?
L-lysine + O2 + H2O
6-amino-2-oxohexanoate + NH3 + H2O2
-
Substrates: -
Products: -
?
L-lysine + O2 + H2O
6-amino-2-oxohexanoate + NH3 + H2O2
-
Substrates: -
Products: -
?
L-lysine + O2 + H2O
6-amino-2-oxohexanoate + NH3 + H2O2
-
Substrates: -
Products: -
?
L-lysine + O2 + H2O
6-amino-2-oxohexanoate + NH3 + H2O2
-
Substrates: most favored substrate
Products: -
?
L-lysine + O2 + H2O
6-amino-2-oxohexanoate + NH3 + H2O2
-
Substrates: -
Products: -
?
L-lysine + O2 + H2O
6-amino-2-oxohexanoate + NH3 + H2O2
Substrates: -
Products: -
?
L-lysine + O2 + H2O
6-amino-2-oxohexanoate + NH3 + H2O2
-
Substrates: preferred substrate
Products: -
?
L-lysine + O2 + H2O
6-amino-2-oxohexanoate + NH3 + H2O2
-
Substrates: also other alpha,omega-diaminomonocarboxylates and L-lysine hydroxamate are oxidized
Products: -
?
L-lysine + O2 + H2O
6-amino-2-oxohexanoate + NH3 + H2O2
-
Substrates: lysine metabolism
Products: -
?
L-lysine + O2 + H2O
6-amino-2-oxohexanoate + NH3 + H2O2
-
Substrates: 100% activity
Products: -
?
L-lysine + O2 + H2O
6-amino-2-oxohexanoate + NH3 + H2O2
Substrates: the molecular mechanism of the strict specificity for L-lysine is explained
Products: -
?
L-lysine + O2 + H2O
6-amino-2-oxohexanoate + NH3 + H2O2
-
Substrates: preferred substrate
Products: -
?
L-lysine + O2 + H2O
6-amino-2-oxohexanoate + NH3 + H2O2
-
Substrates: -
Products: -
?
L-lysine + O2 + H2O
6-amino-2-oxohexanoate + NH3 + H2O2
-
Substrates: 100% activity
Products: -
?
L-ornithine + O2 + H2O
5-amino-2-oxopentanoate + NH3 + H2O2
Substrates: enzymes with dual activities in a single active site: L-lysine oxidase and L-lysine monooxygenase
Products: -
?
L-ornithine + O2 + H2O
5-amino-2-oxopentanoate + NH3 + H2O2
Trichoderma cf. aureoviride
-
Substrates: 5.8% activity compared to L-lysine
Products: -
?
L-ornithine + O2 + H2O
5-amino-2-oxopentanoate + NH3 + H2O2
Trichoderma cf. aureoviride Rifai VKM F-4268D
-
Substrates: 5.8% activity compared to L-lysine
Products: -
?
L-ornithine + O2 + H2O
5-amino-2-oxopentanoic acid + NH3 + H2O2
Substrates: the mechanistic features are reported that are important for allowing the single active site of L-LOX/MOG to catalyze the two reactions of apparent monooxygenation and the oxidation of the flavoprotein oxidase
Products: -
?
L-ornithine + O2 + H2O
5-amino-2-oxopentanoic acid + NH3 + H2O2
-
Substrates: 6% activity compared to L-lysine
Products: -
?
L-ornithine + O2 + H2O
5-amino-2-oxopentanoic acid + NH3 + H2O2
-
Substrates: 8.3% activity compared to L-lysine
Products: -
?
L-ornithine + O2 + H2O
5-amino-2-oxopentanoic acid + NH3 + H2O2
-
Substrates: -
Products: -
?
L-ornithine + O2 + H2O
5-amino-2-oxopentanoic acid + NH3 + H2O2
-
Substrates: -
Products: -
?
L-ornithine + O2 + H2O
5-amino-2-oxopentanoic acid + NH3 + H2O2
-
Substrates: 18.3% activity compared to L-lysine
Products: -
?
L-ornithine + O2 + H2O
5-amino-2-oxopentanoic acid + NH3 + H2O2
-
Substrates: -
Products: -
?
L-ornithine + O2 + H2O
5-amino-2-oxopentanoic acid + NH3 + H2O2
-
Substrates: 18.3% activity compared to L-lysine
Products: -
?
L-phenylalanine + O2 + H2O
phenylpyruvate + NH3 + H2O2
-
Substrates: -
Products: -
?
L-phenylalanine + O2 + H2O
phenylpyruvate + NH3 + H2O2
-
Substrates: -
Products: -
?
L-phenylalanine + O2 + H2O
phenylpyruvate + NH3 + H2O2
-
Substrates: 16% in comparison to L-lysine
Products: -
?
L-phenylalanine + O2 + H2O
phenylpyruvate + NH3 + H2O2
-
Substrates: 1.7% activity compared to L-lysine
Products: -
?
L-phenylalanine + O2 + H2O
phenylpyruvate + NH3 + H2O2
-
Substrates: 16% in comparison to L-lysine
Products: -
?
L-phenylalanine + O2 + H2O
phenylpyruvate + NH3 + H2O2
-
Substrates: 1.7% activity compared to L-lysine
Products: -
?
additional information
?
-
-
Substrates: the enzyme shows no activity with L-histidine, L-aspartic acid, glycine, L-phenylalanine, L-alanine, L-arginine, L-glutamic acid, L-isoleucine, L-leucine, L-serine, L-proline, L-threonine, L-glutamine, L-asparagine, L-threonine, L-tryptophan, L-tyrosine, L-valine, L-methionine, L-cysteine and D-lysine
Products: -
?
additional information
?
-
-
Substrates: very low activity with DL-phenylalanine, L-histidine, L-arginine, DL-methionine and L-glycine
Products: -
?
additional information
?
-
-
Substrates: no activity with L-cysteine, L-asparagine-NH2, DL-serine, DL-asparagine and DL-glutamic acid
Products: -
?
additional information
?
-
-
Substrates: no activity with N-2-trifluoroacetyl-L-lysine, 6-aminocaproic acid, 1,4-diaminobutane, L-alanine, L-leucine, L-glutamic acid, L-2,7-diamino heptanoic acid, L-glutamine, and D-lysine
Products: -
?
additional information
?
-
Trichoderma cf. aureoviride
-
Substrates: no activity with The L-isomers of leucine, phenylalanine, citrulline, alanine, asparagine, histidine, ornithine, glutamine, threonine, tyrosine, isoleucine, valine, as well as glycine and D-lysine
Products: -
?
additional information
?
-
Trichoderma cf. aureoviride Rifai VKM F-4268D
-
Substrates: no activity with The L-isomers of leucine, phenylalanine, citrulline, alanine, asparagine, histidine, ornithine, glutamine, threonine, tyrosine, isoleucine, valine, as well as glycine and D-lysine
Products: -
?
additional information
?
-
-
Substrates: very low activity with DL-phenylalanine and DL-methionine
Products: -
?
additional information
?
-
-
Substrates: no activity with L-cysteine, L-asparagine-NH2, DL-serine, DL-asparagine and DL-glutamic acid
Products: -
?
additional information
?
-
-
Substrates: no activity with L-cysteine, L-asparagine-NH2, DL-serine, DL-asparagine and DL-glutamic acid
Products: -
?
additional information
?
-
-
Substrates: very low activity with several other amino acids
Products: -
?
additional information
?
-
-
Substrates: several amino acids, amino acid derivatives and other substances that are assumed to be possible substrates are tested
Products: -
?
additional information
?
-
-
Substrates: no activity with L-cysteine, L-asparagine-NH2, DL-serine, DL-asparagine and DL-glutamic acid
Products: -
?
additional information
?
-
-
Substrates: commercially manufactured LyOx is generally not highly selective for L-Lys among amino acids
Products: -
?
additional information
?
-
-
Substrates: several amino acids, amino acid derivatives and other substances that are assumed to be possible substrates are tested
Products: -
?
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
L-arginine + O2 + H2O
5-carbamidamido-2-oxopentanoate + NH3 + H2O2
L-lysine + O2 + H2O
6-amino-2-oxohexanoate + NH3 + H2O2
L-ornithine + O2 + H2O
5-amino-2-oxopentanoate + NH3 + H2O2
additional information
?
-
L-arginine + O2 + H2O
5-carbamidamido-2-oxopentanoate + NH3 + H2O2
Trichoderma cf. aureoviride
-
Substrates: 8.3% activity compared to L-lysine
Products: -
?
L-arginine + O2 + H2O
5-carbamidamido-2-oxopentanoate + NH3 + H2O2
Trichoderma cf. aureoviride Rifai VKM F-4268D
-
Substrates: 8.3% activity compared to L-lysine
Products: -
?
L-lysine + O2 + H2O
6-amino-2-oxohexanoate + NH3 + H2O2
-
Substrates: -
Products: -
?
L-lysine + O2 + H2O
6-amino-2-oxohexanoate + NH3 + H2O2
-
Substrates: -
Products: -
?
L-lysine + O2 + H2O
6-amino-2-oxohexanoate + NH3 + H2O2
-
Substrates: -
Products: -
?
L-lysine + O2 + H2O
6-amino-2-oxohexanoate + NH3 + H2O2
-
Substrates: -
Products: -
?
L-lysine + O2 + H2O
6-amino-2-oxohexanoate + NH3 + H2O2
-
Substrates: -
Products: -
?
L-lysine + O2 + H2O
6-amino-2-oxohexanoate + NH3 + H2O2
Trichoderma cf. aureoviride
-
Substrates: -
Products: -
?
L-lysine + O2 + H2O
6-amino-2-oxohexanoate + NH3 + H2O2
Trichoderma cf. aureoviride
-
Substrates: the stereospecific enzyme oxidizes almost exclusively L-lysine
Products: -
?
L-lysine + O2 + H2O
6-amino-2-oxohexanoate + NH3 + H2O2
Trichoderma cf. aureoviride Rifai VKM F-4268D
-
Substrates: the stereospecific enzyme oxidizes almost exclusively L-lysine
Products: -
?
L-lysine + O2 + H2O
6-amino-2-oxohexanoate + NH3 + H2O2
Trichoderma cf. aureoviride Rifai VKM F-4268D
-
Substrates: -
Products: -
?
L-lysine + O2 + H2O
6-amino-2-oxohexanoate + NH3 + H2O2
-
Substrates: -
Products: -
?
L-lysine + O2 + H2O
6-amino-2-oxohexanoate + NH3 + H2O2
-
Substrates: -
Products: -
?
L-lysine + O2 + H2O
6-amino-2-oxohexanoate + NH3 + H2O2
-
Substrates: -
Products: -
?
L-lysine + O2 + H2O
6-amino-2-oxohexanoate + NH3 + H2O2
-
Substrates: most favored substrate
Products: -
?
L-lysine + O2 + H2O
6-amino-2-oxohexanoate + NH3 + H2O2
-
Substrates: -
Products: -
?
L-lysine + O2 + H2O
6-amino-2-oxohexanoate + NH3 + H2O2
Substrates: -
Products: -
?
L-lysine + O2 + H2O
6-amino-2-oxohexanoate + NH3 + H2O2
-
Substrates: preferred substrate
Products: -
?
L-lysine + O2 + H2O
6-amino-2-oxohexanoate + NH3 + H2O2
-
Substrates: also other alpha,omega-diaminomonocarboxylates and L-lysine hydroxamate are oxidized
Products: -
?
L-lysine + O2 + H2O
6-amino-2-oxohexanoate + NH3 + H2O2
-
Substrates: lysine metabolism
Products: -
?
L-lysine + O2 + H2O
6-amino-2-oxohexanoate + NH3 + H2O2
-
Substrates: preferred substrate
Products: -
?
L-lysine + O2 + H2O
6-amino-2-oxohexanoate + NH3 + H2O2
-
Substrates: -
Products: -
?
L-ornithine + O2 + H2O
5-amino-2-oxopentanoate + NH3 + H2O2
Trichoderma cf. aureoviride
-
Substrates: 5.8% activity compared to L-lysine
Products: -
?
L-ornithine + O2 + H2O
5-amino-2-oxopentanoate + NH3 + H2O2
Trichoderma cf. aureoviride Rifai VKM F-4268D
-
Substrates: 5.8% activity compared to L-lysine
Products: -
?
additional information
?
-
Trichoderma cf. aureoviride
-
Substrates: no activity with The L-isomers of leucine, phenylalanine, citrulline, alanine, asparagine, histidine, ornithine, glutamine, threonine, tyrosine, isoleucine, valine, as well as glycine and D-lysine
Products: -
?
additional information
?
-
Trichoderma cf. aureoviride Rifai VKM F-4268D
-
Substrates: no activity with The L-isomers of leucine, phenylalanine, citrulline, alanine, asparagine, histidine, ornithine, glutamine, threonine, tyrosine, isoleucine, valine, as well as glycine and D-lysine
Products: -
?
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Anemia
BAG-1 inhibits p53-induced but not apoptin-induced apoptosis.
Anemia
Proteins selectively killing tumor cells.
Anisakiasis
Purification and cloning of an apoptosis-inducing protein derived from fish infected with Anisakis simplex, a causative nematode of human anisakiasis.
Autoimmune Diseases
Synthesis and structure-activity relationship studies of 2-(1,3,4-oxadiazole-2(3H)-thione)-3-amino-5-arylthieno[2,3-b]pyridines as inhibitors of DRAK2.
Breast Neoplasms
Overexpression of Tumor Protein p53-regulated Apoptosis-inducing Protein 1 Regulates Proliferation and Apoptosis of Breast Cancer Cells through the PI3K/Akt Pathway.
Burkitt Lymphoma
[Effect of L-lysine-alpha-oxidase on the cell cycle kinetics of cultured Burkitt's lymphoma cells]
Carcinoma
[Antimetastatic effect of L-lysine-alpha oxidase]
Carcinoma
[Comparative study of the effect of L-lysine-L-oxidase from Trichoderma harzianum Rifai and Trichoderma viride on nucleic acid synthesis in human tumor cells in vitro]
Carcinoma
[Cytostatic effect of L-lysine-alpha-oxidase from Trichoderma harzianum Rifai and Trichoderma viride]
Carcinoma
[Effect of L-lysine-alpha-oxidase on skin carcinoma induced by methylcholanthrene in mice]
Carcinoma, Hepatocellular
TT virus-derived apoptosis-inducing protein induces apoptosis preferentially in hepatocellular carcinoma-derived cells.
Carcinoma, Lewis Lung
[Antimetastatic effect of L-lysine-alpha oxidase]
Diabetic Retinopathy
Elevation of the vitreous body concentrations of oxidative stress-responsive apoptosis-inducing protein (ORAIP) in proliferative diabetic retinopathy.
Glioblastoma
Unravelling the role of Humanin.
Glioma
Soluble Fas-ligand (sFasL) in human astrocytoma cyst fluid is cytotoxic to T-cells: another potential means of immune evasion.
Hearing Loss
The DFNA5 gene, responsible for hearing loss and involved in cancer, encodes a novel apoptosis-inducing protein.
Herpes Simplex
[Effect of L-lysine-a-oxidase on reproduction of herpes simplex type I virus in vitro]
Herpes Simplex
[Effect of L-lysine-alpha-oxidase gel on development of ophthalmic herpes and herpetic skin lesions in rabbit]
HIV Infections
[Effect of L-lysine-alpha-oxidase on the synthesis of cell proteins, targets of autoimmune pathology in HIV infection]
Hyperlipoproteinemia Type II
Oxidative stress-responsive apoptosis-inducing protein in patients with heterozygous familial hypercholesterolemia.
Hypertension
Haemodynamic and endocrinological changes during anti-hypertensive treatment with a new vasodilator substance (L6150) and propranolol.
Infections
[Effect of L-lysine-A-oxidase on development of herpetic genital infection in guinea pigs]
Leukemia
The use of an enzyme single fiber reactor in the study of leukemic cell proliferation: in vitro experiments and computer simulation.
Leukemia, Lymphocytic, Chronic, B-Cell
DAP Kinase-Related Apoptosis-Inducing Protein Kinase 2 (DRAK2) Is a Key Regulator and Molecular Marker in Chronic Lymphocytic Leukemia.
Melanoma
Proteins selectively killing tumor cells.
Neoplasm Metastasis
Lysyl oxidase: a potential target for cancer therapy.
Neoplasm Metastasis
[Antimetastatic effect of L-lysine-alpha oxidase]
Neoplasms
A Different Path for Harnessing TRAIL.
Neoplasms
AAV-mediated TRAIL gene expression driven by hTERT promoter suppressed human hepatocellular carcinoma growth in mice.
Neoplasms
Apoptin specifically causes apoptosis in tumor cells and after UV-treatment in untransformed cells from cancer-prone individuals: a review.
Neoplasms
Autoimmune lymphoproliferative syndrome: etiology, diagnosis, and management.
Neoplasms
Combination of apoptin with photodynamic therapy induces nasopharyngeal carcinoma cell death in vitro and in vivo.
Neoplasms
Combination therapy with PEG-IFN-alpha and 5-FU inhibits HepG2 tumour cell growth in nude mice by apoptosis of p53.
Neoplasms
Defective apoptosis due to a point mutation in the death domain of CD95 associated with autoimmune lymphoproliferative syndrome, T-cell lymphoma, and Hodgkin's disease.
Neoplasms
Engineering of double recombinant vaccinia virus with enhanced oncolytic potential for solid tumor virotherapy.
Neoplasms
Gene expression profiling of metastatic brain cancer.
Neoplasms
Hepatitis C Virus Core Protein Subverts the Anti-Viral Activities of Human Kupffer Cells.
Neoplasms
Histone deacetylase inhibitors modulate the sensitivity of tumor necrosis factor-related apoptosis-inducing ligand-resistant bladder tumor cells.
Neoplasms
Induction of Cancer Cell Death by Hyaluronic Acid-Mediated Uptake of Cytochrome C.
Neoplasms
Lysyl oxidase: a potential target for cancer therapy.
Neoplasms
Overexpression of Tumor Protein p53-regulated Apoptosis-inducing Protein 1 Regulates Proliferation and Apoptosis of Breast Cancer Cells through the PI3K/Akt Pathway.
Neoplasms
Proteins selectively killing tumor cells.
Neoplasms
Recombinant expression, molecular characterization and crystal structure of antitumor enzyme, l-Lysine ?-oxidase from Trichoderma viride.
Neoplasms
Targeted knockdown of Bcl2 in tumor cells using a synthetic TRAIL 3'-UTR microRNA.
Neoplasms
TAT-apoptin is efficiently delivered and induces apoptosis in cancer cells.
Neoplasms
The DFNA5 gene, responsible for hearing loss and involved in cancer, encodes a novel apoptosis-inducing protein.
Neoplasms
Truncating variants in p53AIP1 disrupting DNA damage-induced apoptosis are associated with prostate cancer risk.
Neoplasms
Tumor counterattack: fact or fiction?
Neoplasms
Tumor prone phenotype of mice deficient in a novel apoptosis-inducing gene, drs.
Neoplasms
[Anti-invasive and anti-metastatic effect of lysine oxidase from Trichoderma sp. in vitro and in vivo]
Neoplasms
[Antimetastatic effect of L-lysine-alpha oxidase]
Neoplasms
[Antitumor enzyme L-lyzine-alpha-oxidase from Trichoderma harzianum Rifai F-180 and investigation of its action on L-lysine oxidation by capillar electrophoresis].
Neoplasms
[Biosynthesis of L-lysine-alpha-oxidase, an antitumor enzyme, by Trichoderma spp]
Neoplasms
[Cytotoxic effect of conjugates of L-lysine-alpha-oxidase with monoclonal antibodies on human tumor cells in vitro]
Neoplasms
[Experimental evaluation of synergism of cisplatin with L-lysine-alpha-oxidase].
Pheochromocytoma
[Effect of L-lysine alpha-oxidase from Trichoderma cf. aureoviride Rifai ???F-4268D on pheochromocytoma PC12 cell line].
Prostatic Neoplasms
Truncating variants in p53AIP1 disrupting DNA damage-induced apoptosis are associated with prostate cancer risk.
Prostatic Neoplasms
Use of the probasin promoter ARR2PB to express Bax in androgen receptor-positive prostate cancer cells.
Prostatic Neoplasms
[Effect of p53-regulated apoptosis-inducing protein 1 transfection on the biological characteristics of PC-3M human prostate cancer cells].
Urinary Bladder Neoplasms
Apoptin induces apoptosis in human bladder cancer EJ and BIU-87 cells.
Urinary Bladder Neoplasms
Histone deacetylase inhibitors modulate the sensitivity of tumor necrosis factor-related apoptosis-inducing ligand-resistant bladder tumor cells.
Urinary Bladder Neoplasms
Sensitization of human bladder tumor cells to TNF-related apoptosis-inducing ligand (TRAIL)-induced apoptosis with a small molecule IAP antagonist.
Virus Diseases
Association of RNase?L with a Ras GTPase-activating-like protein IQGAP1 in mediating the apoptosis of a human cancer cell-line.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.